The impact of epilepsy on subjective health status

Current Neurology and Neuroscience Reports

Volumn 3, Issue 4, 2003, Pages 357-362

  Gilliam, Frank ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ANTICONVULSANT THERAPY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DISABILITY; EPILEPSY; EVIDENCE BASED MEDICINE; FREQUENCY ANALYSIS; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OUTCOMES RESEARCH; QUALITY OF LIFE; RECURRENT DISEASE; RELIABILITY; REVIEW; SEIZURE; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; VALIDATION PROCESS; WELLBEING; ANIMAL; PSYCHOLOGICAL ASPECT;

ANIMALS; EPILEPSY; HEALTH STATUS; HUMANS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0141610209     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0014-0     Document Type: Review

References (46)

1. Hermann BP: The evolution of health-related quality of life assessment in epilepsy. Qual Life Res 1995, 4:87-100.
2. Vickrey BG, Hays RD, Rausch R, et al.: Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia 1994, 35:597-607.
3. Clancy CM, Eisenberg JM: Outcomes research: measuring the end results of health care. Science 1998, 282:245-246.
4. Devinsky O: Outcome research in neurology: incorporating health-related quality of life [editorial; comment]. Ann Neurol 1995, 37:141-142.
5. Gilliam F: Health outcomes in persons with epilepsy. Neurol Clin 2001, 19:465-475.
6. Penfield W, Paine K: Results of surgical therapy for epileptic seizures. Can Med J 1955, 73:515-530.
7. Levin R, Banks S, Berg B: Psychosocial dimensions of epilepsy: a review of the literature. Epilepsia 1988, 29:805-816.
8. Collings JA: Psychosocial well-being and epilepsy: an empirical study. Epilepsia 1990, 31:418-426.
9. Collings JA: Epilepsy and well-being. Soc Sci Med 1990, 31:165-170.
10. Harrison RM, Taylor DC: Childhood seizures: a 25-year follow up. Social and medical prognosis. Lancet 1976, 1:948-951.
11. Guldvog B, Loyning Y, Hauglie-Hanssen E, et al.: Surgical versus medical treatment for epilepsy. II. Outcome related to social areas. Epilepsia 1991, 32:477-486.
12. Ware JE Jr: Standards for validating health measures: definition and content. J Chronic Dis 1987, 40:473-480.
13. Stewart AL, Greenfield S, Harys RD, et al.: Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 1989, 262:907-913.
14. Vickrey BG, Hays RD, Graber J, et al.: A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992, 30:299-319.
15. Devinsky O, Vickrey BG, Cramer J, et al.: Development of the quality of life in epilepsy inventory. Epilepsia 1995, 36:1089-1104.
16. Baker GA: Quality of life and epilepsy: the Liverpool experience. Clin Ther 1998, 20(suppl A):A2-12.
17. O'Donoghue MF, Duncan JS, Sander JW: The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain 1998, 121(Pt 2):317-343.
18. Patrick DL, Deyo RA: Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989, 27(suppl 3):S217-232.
19. Baker GA, Jacoby A, Buck D, et al.: Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
20. Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
21. Sillanpaa M, Jalava M, Kaleva O, et al.: Long-term prognosis of seizures with onset in childhood [see comments]. N Engl J Med 1998, 338:1715-1722.
22. Mattson RH, Cramer JA, and Collins JF: Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology 1996, 47:68-76.
23. Leidy NK, Elixhauser A, Vickrey B, et al.: Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999, 53:162-166.
24. Vickrey BG, Hays RD, Engel J Jr, et al.: Outcome assessment for epilepsy surgery: the impact of measuring health- related quality of life [see comments]. Ann Neurol 1995, 37:158-166.
25. Blum DE, Eskola J, Bortz JJ, et al.: Patient awareness of seizures. Neurology 1996, 47:260-264.
26. Vickrey BG, Berg AT, Sperling MR, et al.: Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000, 41:760-764.
27. Jacoby A, Baker GA, Steen N, et al.: The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996, 37:148-161.
28. Edeh J, Toone B: Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987, 151:95-101.
29. Mendez MF, Cummings JL, Benson DF: Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986, 43:766-770.
30. Perrine K, Hermann BP, Meador KJ, et al.: The relationship of neuropsychological functioning to quality of life in epilepsy [see comments]. Arch Neurol 1995, 52:997-1003.
31. Hermann BP, Seidenberg M, Bell B, et al.: Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life. Epilepsy Behav 2000, 1:184-190.
32. Gilliam F, Kuzniecky R, Meador K, et al.: Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy [see comments]. Neurology 1999, 53:687-694.
33. Vickrey BG, Hays RD, Rausch R, et al.: Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet 1995, 346:1445-1449.
34. McLachlan RS, Rose KJ, Derry PA, et al.: Health-related quality of life and seizure control in temporal lobe epilepsy. Ann Neurol 1997, 41:482-489.
35. Markand ON, Salanova V, Whelihan E, et al.: Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia 2000, 41:749-759.
36. Wiebe S, Blume WT, Girvin JP, et al.: A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001, 345:311-318.
37. Cramer JA, Arrigo C, Van Hammee G, et al.: Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group. Epilepsia 2000, 41:868-874.
38. Cramer JA: Exploration of changes in health-related quality of life after 3 months of vagus nerve stimulation. Epilepsy Behav 2001, 2:460-465.
39. Dodrill CB, Morris GL: Effects of vagal nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav 2001, 2:46-53.
40. Gilliam F, Kuzniecky R, Faught E, et al.: Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997, 38:233-236.
41. Gilliam F: Optimizing health outcomes in active epilepsy. Neurology 2002, 58(8 suppl 5):S9-S20.
42. Baker GA, Frances P, Middleton E: Initial development, reliability, and validity of a patient-based adverse events scale. Epilepsia 1994, 35(suppl 7):80.
43. Lustman PJ, Clouse RE, Griffith LS, et al.: Screening for depression in diabetes using the Beck Depression Inventory [see comments]. Psychosom Med 1997, 59:24-31.
44. Kanner AM, Nieto JC: Depressive disorders in epilepsy. Neurology 1999, 53(5 suppl 2):S26-32.
45. Kanner AM, Palac S: Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 2000, 1:37-51.
46. Barry JJ, Huynh N, Lembke A: Depression in individuals with epilepsy. Curr Treat Options Neurol 2000, 2:571-585.